Patents matching “modified”

US 7303754

MVA expressing modified HIV envelope, gag, and pol genes

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2007 · Expires Nov 29, 2027

US 7294699

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Nov 13, 2007 · Expires Nov 8, 2027

US 7271150

Modified growth hormone

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2007 · Expires Sep 13, 2027

US 7261900

Recombinant modified Bacillus anthracis protective antigen for use in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 28, 2007 · Expires Aug 23, 2027

US 7253147

Modified serum albumin with reduced affinity for nickel and copper

New Century Pharmaceuticals, Inc. · Granted Aug 7, 2007 · Expires Aug 2, 2027

US 7247708

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Jul 24, 2007 · Expires Jul 19, 2027

US 7223388

Modified reoviral therapy

The Board of Regents of the University of Texas System · Granted May 29, 2007 · Expires May 24, 2027

US 7220837

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted May 22, 2007 · Expires May 17, 2027

US 7150869

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7119066

Modified ciliary neurotrophic factor (CNTF)

REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2006 · Expires Oct 5, 2026

US 7109303

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Sep 19, 2006 · Expires Sep 14, 2026

US 7074410

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 11, 2006 · Expires Jul 6, 2026

US 7070959

Modified chimeric polypeptides with improved pharmacokinetic properties

REGENERON PHARMACEUTICALS, INC. · Granted Jul 4, 2006 · Expires Jun 29, 2026

US 7067122

Modified live Edwardsiella tarda vaccine for aquatic animals

The United States of America, as represented by the Secretary of Agriculture · Granted Jun 27, 2006 · Expires Jun 22, 2026

US 7049116

Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 23, 2006 · Expires May 18, 2026

US 7041503

Modified myelin basic protein molecules

The United States of America, as represented by the Department of Health and Human Services · Granted May 9, 2006 · Expires May 4, 2026

US 7029899

Selective toxicity of amino-terminal modified rnase a superfamily polypeptides

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 18, 2006 · Expires Apr 13, 2026

US 6991793

Method of protecting fish against columnaris disease with modified live Flavobacterium columnare

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 31, 2006 · Expires Jan 26, 2026

US 6890518

Compositions of chemically modified insulin

Nektar Therapeutics · Granted May 10, 2005 · Expires May 5, 2025

US 6884788

Thiol-modified hyaluronan

ANIKA THERAPEUTICS, INC. · Granted Apr 26, 2005 · Expires Apr 21, 2025

US 6881412

Modified live Flavobacterium columnare against columnaris disease in fish

The United States of America, as represented by the Secretary of the Agriculture · Granted Apr 19, 2005 · Expires Apr 14, 2025

US 6867289

Thio-modified aptamer synthetic methods and compositions

The Board of Regents of the University of Texas System · Granted Mar 15, 2005 · Expires Mar 10, 2025

US 6838076

Pulmonary administration of chemically modified insulin

Nektar Therapeutics · Granted Jan 4, 2005 · Expires Dec 30, 2024

US 6787636

Modified serum albumin with reduced affinity for nickel and copper

New Century Pharmaceuticals, Inc. · Granted Sep 7, 2004 · Expires Sep 2, 2024